India to Kenya: Ceftriaxone Export Trade Route

The India to Kenya Ceftriaxone corridor is one of India's established pharmaceutical export routes, with 1,000 shipments documented worth a combined $50.6M USD. The route is dominated by INNOVA CAPTAB LIMITED, which alone accounts for roughly 62% of all export value, reflecting the consolidated nature of India's ceftriaxone manufacturing sector.

Across 116 active suppliers, the average shipment value stands at $50.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with ceftriaxone's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 31.1%, placing it at rank #6 among India's top ceftriaxone export destinations globally.

On the import side, key buyers of Indian ceftriaxone in Kenya include ROYAL PHARMA 2011 LIMITED, ABACUS PHARMA (AFRICA) LTD, SYNER-MED PHARMACEUTICALS(KENYA) and 180 others. ROYAL PHARMA 2011 LIMITED is the single largest importer with 128 shipments valued at $29.7M USD.

India's ceftriaxone exports to Kenya are driven primarily by a handful of large-scale manufacturers. INNOVA CAPTAB LIMITED with 292 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 116 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INNOVA CAPTAB LIMITED, ZYDUS LIFESCIENCES LIMITED, THEON PHARMACEUTICALS LIMITED — together account for 69% of total trade value on this route. The average shipment value of $50.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as zefone 1gm injection 1vial uganda (ceftriaxone sodium) (as per inv & pl) and monotax inj 1 gm (with wfi) (ceftriaxone , suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ROYAL PHARMA 2011 LIMITED is the largest importer with 128 shipments worth $29.7M USD — representing 59% of all ceftriaxone imports from India on this route. A total of 183 buyers are active on this corridor.